Welcome to the National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre (BRC); based on the Cambridge Biomedical Campus, it combines on a single site scientific research in world-class institutes, patient care in NHS hospitals, and drug discovery in pharmaceutical companies including AstraZeneca and GlaxoSmithKline (GSK).
The NIHR Cambridge BRC reaches out to scientists on the campus and beyond to ensure that their discoveries are pulled into the NHS, where clinical researchers can use them, in partnership with the life sciences industry, to improve health.
It creates an environment that engages patients and the public, trains and nurtures the next generation of researchers, promotes equality and is diverse, and encourages all staff working in the NHS to engage in research.
Over the next five years the NIHR Cambridge BRC plans to work on cancer, cardiovascular and respiratory disease, dementia, disorders of the nervous system and mental health, infections and their resistance to antibiotics, obesity and diabetes, bone disease, digestive disorders and the effect of nutrition, diet and lifestyle on health, transplantation and the use of stem cells to repair tissues, and women’s and children’s health.
In addition, the Cambridge BRC has received funding from the Government to establish the NIHR BioResource for Translational Research in Common and Rare Diseases, building on the success of the NIHR BioResource and NIHR Rare Diseases Translational Research Collaboration.
A parallel designation and funding of the Cambridge Clinical Research Facility as an NIHR Clinical Research Facility for Experimental Medicine was awarded for the period 2017 – 2022.
I invite you now to read through our work to gain a better understanding of the NIHR Cambridge BRC and hope you will consider supporting and joining us in future projects.
Professor John Bradley, Director NIHR Cambridge BRC